Text Me, Girl!
Resource from the RWHAP Best Practices Compilation updated on 04/01/2024
Resource from the RWHAP Best Practices Compilation updated on 04/01/2024
Resource from the RWHAP Best Practices Compilation updated on 02/20/2024
Resource (Conference Presentation) updated 09/14/2023
Results of SPNS initiative's virtual field visits to identify rapid ART implementation insights in RWHAP settings across the U.S.
Resource (Conference Presentation) updated 09/14/2023
Review of challenges, facilitators, and best practices for routine screening, linkage, and rapid ART in two emergency departments, including during COVID-19.
Resource (Conference Presentation) updated 09/14/2023
Review of rapid antiretroviral treatment programs implemented at 15 Virginia RWHAP sites, including insights and future quality improvement activities focused on the Ending the Epidemic initiative.
Resource (Conference Presentation) updated 12/11/2023
Description of various models in the RWHAP SPNS Rapid Start initiative and data on their impact, using initiative-wide data.
Resource (Conference Presentation) updated 09/14/2023
Two-year retrospective exploring innovative approaches to reduce stigma and isolation among cis and transgender women of color with HIV, including women with HIV residing in rural areas not connected to care.
Resource (Conference Presentation) updated 09/14/2023
Collaboration work that increased equitable access to HIV, Hepatitis C, and STD prevention, testing, treatment, and care services for rural residents.
Resource (Conference Presentation) updated 09/14/2023
Review of challenges, facilitators, and best practices for routine screening, linkage, and rapid ART in two emergency departments, including during COVID-19.
Resource (Conference Presentation) updated 09/14/2023
Same Day Start rapid ART program in Kansas City, under which 74 percent of participants reaching viral suppression.
Resource (Conference Presentation) updated 09/14/2023
Outreach strategies to better serve rural MSM populations impacted by cultural, geographic, and resource-related barriers to HIV testing.
Resource (Conference Presentation) updated 09/14/2023
Discussion on how to leverage CAREWare data integration to develop an innovative data reporting tool to assist with a community-wide Rapid stART protocol
Resource (Conference Presentation) updated 09/14/2023
Discussion of how to leverage a learning collaborative methodology to plan, implement, and sustain a jurisdiction-wide Rapid stART initiative.
Resource (Conference Presentation) updated 09/14/2023
Session on a rural clinic's work and adjustments during COVID-19. Presentation from the Division of Community HIV/AIDS Programs (DCHAP) Business Day Meeting held at the 2022 National Ryan White Conference.
Resource (Conference Presentation) updated 09/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Review of data on delivery of rapid start of ART among New Jersey providers, including, for example, provision of same-day medical appointments, extended office hours, and comfort administering rapid start with high need patients.
Resource (Conference Presentation) updated 12/11/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Significant challenges exist in vaccinating people with HIV for COVID-19. Our RWPC program set out to implement and evaluate a vaccine initiative for COVID-19 for people with HIV. We achieved vaccine rates of 78 percent being fully vaccinated by December 1, 2021 and 30 percent having a third dose.
Resource (Conference Presentation) updated 09/14/2023